Rex Bionics Plc, through its 36% interest in Rex Bionics Pty Ltd., engages in the research and development, manufacture, and commercialization of advanced robotic devices. The company offers its products to provide physiotherapy to and enhance the physical and psychological well-being of people with major mobility impairment as a result of spinal cord injury or other neurological damage. It offers its products primarily in Australia, New Zealand, and North America. The company was formerly known as Union MedTech Plc and changed its name to Rex Bionics Plc in May 2014. Rex Bionics Plc was incorporated in 2007 and is based in London, the United Kingdom.